Updated 08/04/2021 1:32 PM
In the midst of the controversy over the delay in the shipment of the second component of Sputnik V, Russia said on Wednesday that "a large increase in production capacity" will allow it to
resolve "completely the delays" this month.
"The Sputnik V team confirms that in August all temporary delays in the delivery of the second component of the vaccine will be completely resolved. This is due to the
large increase in the production capacity of the vaccines,
" they reported through of a statement.
The possibility of considerably increasing production was ratified by Russia after the signing of manufacturing agreements with different countries.
"Sputnik V has established production agreements with manufacturers from 14 countries and will
double its capacity in September
thanks to the association with large firms such as the Serum Institute of India, the largest producer of vaccines in the world," it adds in the text.
LAST MINUTE: The Sputnik V team confirms that thanks to an increase in vaccine production capacity, temporary delays in the delivery of the second component will be fully resolved during the month of August.
- Sputnik V (@sputnikvaccine) August 4, 2021
The statement noted that the demand for Sputnik V vaccines is very high "due to their exceptional efficacy and safety, as well as the absence of serious side effects that have been linked to the use of some other vaccines."
And he adds: "In countries where Sputnik V is used as part of national vaccination campaigns, especially in Argentina and Mexico, a constant decrease in COVID-19 cases is observed. A study by the Gamaleya Center published in the medical journal International Vaccines showed that Sputnik V is one of the most efficient vaccines against variants of the coronavirus, including Delta. "
The statement comes hours before the presentation by the Government of the results of the vaccine combination, which began some time ago precisely due to the delay in the arrival of the second component of Sputnik V.
However, the Government had already advanced that despite the possibility of advancing in the combination of doses from different laboratories, they expected to receive more second components of Sputnik V.
The document also noted that "Sputnik V will also continue to play a leading role in vaccine combinations."
"The vaccine pioneered the heterogeneous booster approach ('vaccine cocktail') by using two different adenoviral vectors (Ad5 and Ad26) for two different injections. And it was
the first to offer a joint trial of mix and match
to another producer when he made an offer to AstraZeneca on November 23, 2020, "the text states.
In addition, it maintains that "joint trials of Sputnik V and AstraZeneca have been ongoing in the United Arab Emirates, Azerbaijan and Argentina since February 2021. The first positive results were announced on July 30. More positive results are expected this week on immunogenicity ".
This Wednesday, the Minister of Health, Carla Vizzotti, will announce, together with the Ministers of Health of the City and the province of Buenos Aires, Fernán Quirós and Nicolás Kreplak, the results of the vaccine combination studies against the coronavirus.
According to the official, the objective is that during the month of August the schedules of those who received a single dose of Sputnik begin to be completed, applying AstraZeneca, Sinopharm or Moderna vaccines as second doses.
The results of the combination of vaccines, whose trials were carried out in the country during the last month, will allow millions of people who today have the first dose of the Sputnik V vaccine to receive another in replacement of the second component.
The idea is that it is optional.
Coronavirus: the Government confirmed that the first doses of the Pfizer vaccine arrive in September
Vaccine combination: what health passport will those who choose to replace the second component of Sputnik have